Halozyme Therapeutics shares owned by PENN Capital Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by PENN Capital Management
from 13F filings
Historical chart of PENN Capital Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by PENN Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by PENN Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $15M | 266k | 57.40 |
| 2024-06-30 | $16M | 301k | 52.55 |
| 2024-03-31 | $11M | 273k | 40.83 |
| 2023-12-31 | $10M | 280k | 37.10 |
| 2023-09-30 | $13M | 325k | 38.35 |
| 2023-06-30 | $10M | 287k | 36.07 |
| 2023-03-31 | $11M | 286k | 38.60 |
| 2022-12-31 | $16M | 287k | 57.13 |
| 2022-09-30 | $2.6M | 65k | 40.32 |
| 2022-06-30 | $13M | 300k | 44.00 |
| 2022-03-31 | $8.3M | 225k | 37.08 |
| 2021-12-31 | $11M | 279k | 40.58 |
| 2021-09-30 | $12M | 290k | 40.68 |
| 2021-06-30 | $13M | 277k | 45.41 |
| 2021-03-31 | $11M | 269k | 41.69 |
| 2020-12-31 | $10M | 241k | 42.71 |
| 2020-09-30 | $7.8M | 293k | 26.53 |
| 2020-06-30 | $7.8M | 290k | 27.03 |
| 2020-03-31 | $5.1M | 284k | 18.01 |